Funds holding Artiva Biotherapeutics Inc
ISIN US04317A1079 · United States
- Fund holders
- 19
- Of which ETFs
- 4 15 other funds
- Value held
- 4.7M $
- Share of capital
- 1.2 % of 48.9M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 192,871 | 2M $ | 0.19 % | 0.39 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 148,199 | 954.4K $ | 0.30 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 59,487 | 383.1K $ | 0.00 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 35,000 | 225.4K $ | 0.18 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 34,690 | 201.9K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 23,230 | 149.6K $ | 0.22 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 22,175 | 129.1K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Nationwide Bailard Small Cap Value Fund Nationwide Mutual Funds | 20,700 | 212K $ | 0.17 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 18,626 | 108.4K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 14,965 | 87.1K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 8,845 | 57K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 8,171 | 83.7K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 8,018 | 51.6K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 3,040 | 31.1K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 3,029 | 31K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 2,634 | 27K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 915 | 5.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 678 | 6.9K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 483 | 3.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 0.22 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.19 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.18 % | as of Mar 31, 2026 ↗ |
| Nationwide Bailard Small Cap Value Fund Nationwide Mutual Funds | 0.17 % | as of Apr 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 19 | +4 | 605,756 | +10.6 % |
| 2026Q1 | 15 | +1 | 547,625 | -3.4 % |
| 2025Q4 | 14 | -27 | 566,900 | -41.9 % |
| 2025Q3 | 41 | -38 | 975,350 | -69.6 % |
| 2025Q2 | 79 | +4 | 3,209,054 | +6.7 % |
| 2025Q1 | 75 | +18 | 3,006,338 | +18.7 % |
| 2024Q4 | 57 | +56 | 2,532,948 | +1,592.4 % |
| 2024Q3 | 1 | 149,666 |
Institutional managers
38 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9,853,302 | 63.5M $ | as of Mar 31, 2026 |
| 5AM Venture Management, LLC | 2,353,304 | 15.2M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 1,609,569 | 10.4M $ | as of Mar 31, 2026 |
| venBio Partners LLC | 531,337 | 3.4M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 520,327 | 3.4M $ | as of Mar 31, 2026 |
| Revelation Capital Management, LLC | 299,311 | 1.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 213,388 | 1.4M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 194,108 | 1.3M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 146,369 | 949.8K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 123,270 | 793.9K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 115,041 | 740.9K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 101,695 | 655.5K $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 100,000 | 644K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 80,038 | 515.4K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 39,496 | 254.4K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 35,824 | 230.7K $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,000 | 225.4K $ | as of Mar 31, 2026 |
| PANAGORA ASSET MANAGEMENT INC | 30,702 | 197.7K $ | as of Mar 31, 2026 |
| Velan Capital Investment Management LP | 25,000 | 161K $ | as of Mar 31, 2026 |
| Simplify Asset Management Inc. | 23,230 | 149.6K $ | as of Mar 31, 2026 |
| Sanctuary Advisors, LLC | 21,581 | 139K $ | as of Mar 31, 2026 |
| BAILARD, INC. | 20,700 | 133.3K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 20,370 | 131.2K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 20,270 | 130.5K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 16,377 | 105.5K $ | as of Mar 31, 2026 |
Declared shareholders of Artiva Biotherapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RA Capital Management, L.P. and 3 others | 36.60 % | 17,811,623 | as of Jun 11, 2026 · SCHEDULE 13D |
| GC Corp and 2 others | 12.30 % | 5,999,703 | as of May 11, 2026 · SCHEDULE 13D |
| VIKING GLOBAL INVESTORS LP and 9 others | 5.40 % | 2,604,166 | as of May 11, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Artiva Biotherapeutics Inc". https://titelia.com/en/stocks/artiva-biotherapeutics-inc-US04317A1079